Chordate Medical Holding AB (publ) (STO:CMH)
Sweden
· Delayed Price · Currency is SEK 6.42
+0.10 (1.58%)
Apr 30, 2025, 11:48 AM CET
Chordate Medical Holding AB Company Description
Chordate Medical Holding AB (publ), a medical technology company, engages in the development of products and solutions for the treatment of chronic migraine and rhinitis in Sweden.
It offers Ozilia, a neuromodulation and drug-free treatment technology for chronic migraine and chronic rhinitis.
The company was founded in 2005 and is based in Kista, Sweden.
Chordate Medical Holding AB (publ)
| Country | Sweden |
| Founded | 2005 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Anders Weilandt |
Contact Details
Address: KistagAngen 20B Kista, 164 40 Sweden | |
| Phone | 46 8 40 01 15 86 |
| Website | chordate.com |
Stock Details
| Ticker Symbol | CMH |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0009495559 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Anders Weilandt | Chief Executive Officer and MD |
| Niklas Lindecrantz | Chief Financial Officer |
| Jan Lindberg | Chief Technology Officer and Head of Research & Development, Production and Quality |
| Jan Hermansson | Chief Scientific Officer and Clinical Research and Medical Director |